Russell Publishing

What Russell Publishing does

Russell Publishing Limited is a UK-based, family-owned independent B2B media company founded in 1992 by Ian Russell and headquartered in Brasted, Kent, with a 51-100 employee headcount operating under a hybrid working model. The company delivers business information to four distinct professional verticals — international rail, pharmaceutical and drug discovery, food manufacturing, and airport/aviation — through a paired portfolio of five publications and five dedicated events platforms. Its owned brands are Global Railway Review, International Airport Review, Drug Target Review, European Pharmaceutical Review, and New Food, complemented by Drug Discovery Events, Pharmaceutical Events, New Food Events, Global Railway Events, and International Airport Events.

The underlying technology stack is conventional B2B digital media infrastructure rather than a proprietary platform: WordPress-style CMS-hosted websites for each title, Google Analytics and Universal Analytics for traffic measurement, Communigator for email marketing and UTM tracking, and event ticketing systems for the conference business. Russell Publishing does not maintain a mobile app, public API, or SDK, and there are no disclosed AI/ML capabilities, patents, or proprietary data products.

The business model combines three revenue streams: recurring publication subscriptions across the magazine and digital editions, digital advertising and sponsored content on the five vertical websites, and event/conference sponsorships and ticketing across the five events platforms. Go-to-market is a hybrid of content-led audience development (organic social on Facebook, Twitter/X, and LinkedIn, plus email newsletters) and direct sales into B2B advertisers and event sponsors. The company is privately held with no institutional investors or disclosed funding, and there are no named advertiser or sponsor customers, partnerships, or acquisition activity in the public record.

Name

Russell Publishing

Legal name

Russell Publishing Limited

Website

https://russellpublishing.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

51–100 employees

Short description

Russell Publishing is a UK family-owned B2B media company founded in 1992 that serves the rail, pharmaceutical, food manufacturing, and airport sectors through five niche trade publications and five parallel events platforms, monetising via subscriptions, digital advertising, and conferences.

Ownership category

akta.pro rank

Product category

B2B Trade Publishing

NAICS

Periodical Publishers (513120)

SIC

Periodicals: Publishing Or Publishing & Printing (2721)

akta.pro primary industry

Business, Finance & Industry Trade Magazines (MPAJAEAM)

akta.pro secondary industries

Food, Cooking & Beverage Magazines (MPAJAEAF), Automotive & Transportation Magazines (MPAJAEAI)

Keywords

• B2B trade publishing
• Industry magazines
• Sector events conferences
• Digital publishing platforms
• Vertical media brands

Headquarters

HQ city

Westerham

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Publishing Subscriptions: Business information provided in the form of magazines and digital publications across rail, pharmaceutical, food manufacturing and airport sectors, likely through subscription model.
2. Events and Conferences: Events and conferences for food, rail and airport sectors that bring together industry leaders from across the globe to network, learn and debate the latest issues and technologies.
3. Digital Advertising: Digital advertising and marketing services delivered through industry-specific websites and publications, with featured content provider and advertiser relationships.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Russell Publishing provides business information across the rail, pharmaceutical, food manufacturing, and airport sectors in the form of magazines, websites, events, and conferences. It operates a portfolio of five specialist trade publications (Global Railway Review, International Airport Review, Drug Target Review, European Pharmaceutical Review, and New Food) alongside five dedicated events platforms serving professionals in each vertical industry.

Product overview

Russell Publishing is a dynamic, independent media company that provides industry-led insights for the Rail, Pharmaceutical, Drug Discovery, Food Manufacturing and Airport sectors. The company operates a portfolio of five core publications (Global Railway Review, International Airport Review, Drug Target Review, European Pharmaceutical Review, and New Food) alongside five dedicated events platforms (Drug Discovery Events, Pharmaceutical Events, New Food Events, Global Railway Events, and International Airport Events) that bring together industry leaders across these sectors. This multi-brand publishing model delivers magazines, websites, conferences, webinars and digital media content tailored to each vertical industry.

Differentiator

Problem solved

Functional benefit

Brands

• Global Railway Review: An essential source of news, expert analysis and insight for the international rail industry, exploring all the major global trends and topics impacting the sector.
• International Airport Review
• Drug Target Review
• European Pharmaceutical Review
• New Food

Products and services

• Global Railway Review A trade publication providing news, expert analysis, and insight on global trends and topics impacting the international rail industry, for railway professionals and organizations worldwide.
• International Airport Review A trade publication delivering in-depth articles, news, and opinion from the world's leading airports, airlines, and supply chain partners, serving as a primary reference for the airport and aviation community.
• Drug Target Review A trade publication promoting the latest research, funding projects, and cutting-edge technological developments in the drug discovery industry.
• European Pharmaceutical Review A trade publication providing quality up-to-the-minute information on drug analysis, formulation, delivery, manufacturing, and regulation, written by experts for pharmaceutical industry professionals.
• New Food A trade publication serving as a thought leadership platform for the food and beverage industry, covering food safety, quality control, and scientific innovation.
• Drug Discovery Events An events and conferences platform for the drug discovery industry, bringing together industry leaders to network, learn, and debate the latest issues and technologies.
• Pharmaceutical Events An events and conferences platform for the pharmaceutical sector, bringing together industry leaders to network, learn, and debate the latest issues and technologies.
• New Food Events An events and conferences platform for the food sector, bringing together industry leaders to network, learn, and debate the latest issues and technologies.
• Global Railway Events An events and conferences platform for the rail industry, bringing together industry leaders to network, learn, and debate the latest issues and technologies.
• International Airport Events An events and conferences platform for the airport sector, bringing together industry leaders to network, learn, and debate the latest issues and technologies.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Informa plc: Global B2B media, events, and information services group operating across many of the same verticals (pharma, food, transport) at much larger scale. Comparable as the dominant B2B trade media and events incumbent Russell Publishing operates within.
• RELX (Reed Elsevier): Global information and analytics business with strong positions in scientific, medical, and risk/transport information. Overlaps with Russell's pharmaceutical and rail verticals as a much larger incumbent.
• Haymarket Media Group: Privately held global B2B and consumer media company with multiple specialist brands and events. Operates a similar multi-brand B2B media portfolio, including overlaps in transport and professional verticals.
• Springer Nature: Major academic and professional publisher with strong pharmaceutical and life sciences content. Overlaps with Russell's European Pharmaceutical Review and Drug Target Review brands in pharma information.

Direct peers

• Wilmington plc: UK-listed B2B media and information business with a portfolio of specialist events, publications, and data products across regulated verticals. Closely comparable in size and in the multi-vertical B2B media + events operating model Russell Publishing follows.
• Mercator Media: UK-based B2B media company producing specialist magazines, websites and events for the rail and transport sectors. Directly comparable as a niche trade publisher/events operator in a vertical that Russell Publishing also serves via Global Railway Review.
• CloserStill Media: UK-based organiser of B2B exhibitions and conferences across healthcare, pharma, and technology verticals. Directly comparable in the events-led B2B media model and overlapping pharma vertical focus.
• MA Business (MA Media): UK B2B media business producing specialist trade magazines and events across industrial and transport sectors. Closely comparable in size, model, and B2B trade publishing approach to Russell Publishing.

Emerging players

• GlobalData: Listed data and analytics provider serving multiple B2B verticals including pharma, food, and transport. Comparable as a higher-end information and data product alternative that competes for the same B2B marketing budgets.
• Step Exhibitions: Specialist organiser of B2B conferences and exhibitions in pharma and life sciences. Comparable as a focused events operator that overlaps with Russell's pharmaceutical and drug discovery event platforms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Russell Publishing